Article
Developmental Inhibition of Gsk3 Rescues Behavioral and Neurophysiological Deficits in a Mouse Model of Schizophrenia Predisposition.
Neuron - 2 Mar 2016
Tamura Makoto, Mukai Jun, Gordon Joshua A, Gogos Joseph A
Abstract excerpt
While the genetic basis of schizophrenia is increasingly well characterized, novel treatments will require establishing mechanistic relationships between specific risk genes and core phenotypes. Rare, highly penetrant risk genes such as the 22q11.2 microdeletion are promising in this regard. Df(16)A(+/-) mice, which carry a homologous microdeletion, have deficits in hippocampal-prefrontal connectivity that...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
